December 17, 2022

Transmural Remission Characterized by High Biologic Concentrations Demonstrates Better Prognosis in Crohn’s Disease

Key Points

Key points are not available for this paper at this time.

Abstract

Transmural remission was the best predictor for prognosis in CD patients who received maintenance biologic therapy. High drug concentration levels were associated with transmural remission confirmed via MRE.

Bookmark

Cite This Study

Takenaka et al. (Sat,) studied this question.

synapsesocial.com/papers/69d732cef07a12db70b8a3cf https://doi.org/https://doi.org/10.1093/ecco-jcc/jjac185

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Tumor necrosis factor antagonist mechanisms of action: A comprehensive review2007 · 1,618 citations
2The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications2006 · 3,156 citations
3Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s Disease2019 · 216 citations
4Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn’s disease2020 · 86 citations
5Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics2014 · 84 citations